Macronutrient-based interventions and TB treatment outcomes: a scoping review
The International Journal of Tuberculosis and Lung Disease · 2026-10-30 · 30 (11) · 474-484
DOI: 10.5588/ijtld.26.0395 ↗Abstract
INTRODUCTION
Macronutrients may influence TB outcomes through biological and clinical mechanisms. We conducted a scoping review to map evidence on macronutrient-based nutritional interventions during TB treatment and their associations with treatment outcomes and clinical recovery.
METHODS
Following Joanna Briggs Institute guidelines, a protocol was prospectively registered. We systematically searched MEDLINE, Embase, Global Health, Food Science and Technology Abstracts, and Web of Science from inception to March 2026. Eligible peer-reviewed studies included participants with active TB, evaluated macronutrient-based interventions, and reported treatment outcomes. Findings were summarised narratively and in tables.
RESULTS
Of 5,578 records screened, 14 studies involving 7,298 adults (17–82 years) met inclusion criteria. Interventions included food baskets or household rations, ready-to-use nutritional supplements, nutritional counselling, or combinations thereof. Protein was the most commonly targeted macronutrient. Outcomes assessed included treatment completion (n = 8), mortality (n = 7), treatment failure (n = 6), loss to follow-up (n = 6), treatment success (n = 4), cure (n = 4), sputum smear or culture conversion (n = 4), and adherence (n = 4).
CONCLUSION
Macronutrient-based interventions may improve TB treatment outcomes and support clinical recovery, but evidence remains heterogeneous in design and outcome reporting. Further well-designed studies using standardised outcome measures are needed to inform integration of nutritional support into TB care.
EUVIMED